期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 255, 期 1-2, 页码 17-22出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2007.01.057
关键词
amyotrophic lateral sclerosis; ALS; motor neuron disease; astrocytosis; PET; MAO-B; deprenyl
Objective: To use deuterium-substituted [C-11](L)-deprenyl PET to depict astrocytosis in vivo in patients with amyotrophic lateral sclerosis (ALS). Background: In human brain, the enzyme MAO-B is primarily located in astrocytes. L-deprenyl binds to MAO-B and autoradiography with H-3-L-deprenyl has been used to map astrocytosis in vitro, Motor neuron loss in ALS is accompanied by astrocytosis and astrocytes may play an active role in the neurodegenerative process. Deuterium-substituted [C-11](L)-deprenyl PET provides an opportunity to localize astrocytosis in vivo in the brain of patients with ALS. Methods: Deuterium-substituted [C-11](L)-deprenyl PET was performed in seven patients with ALS and seven healthy control subjects. Results: Increased uptake rate Of [C-11](L)-deprenyl was demonstrated in ALS in pons and white matter. Conclusion: This Study provides evidence that astrocytosis may be detected in vivo in ALS by the use of deuterium-substituted [C-11](L)deprenyl PET though further studies are needed to determine whether deuterium-substituted [C-11](L)-deprenyl binding tracks disease progression and reflects astrocytosis. (c) 2007 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据